What are the diagnostic criteria for rheumatic fever in a child or young adult with a recent streptococcal infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Rheumatic Fever

Diagnose acute rheumatic fever using the revised Jones Criteria, which requires evidence of preceding group A streptococcal infection PLUS either 2 major manifestations OR 1 major and 2 minor manifestations, with different thresholds for low-risk versus moderate-to-high-risk populations. 1

Essential First Step: Document Streptococcal Infection

Before applying the Jones Criteria, you must demonstrate evidence of recent group A streptococcal (GAS) infection through one of these methods: 1

  • Positive throat culture or rapid antigen detection test (RADT) - though these are often negative by the time rheumatic fever develops 1
  • Elevated or rising anti-streptolysin O (ASO) titer - begins rising ~1 week after infection, peaks at 3-6 weeks 2, 3
  • Elevated anti-DNase B titer - begins rising 1-2 weeks after infection, peaks at 6-8 weeks 2, 3
  • Combined ASO and anti-DNase B testing detects up to 98% of proven streptococcal cases 4

Critical caveat: At least one-third of rheumatic fever cases result from inapparent streptococcal infections, making documentation challenging. 1 Anti-streptococcal antibody titers reflect past infection only and cannot diagnose acute pharyngitis. 1, 2

Major Manifestations (Population-Specific)

The 2015 AHA revision stratifies criteria based on population risk: 1

Low-Risk Populations (e.g., United States, Western Europe):

  • Carditis (clinical and/or subclinical by echocardiography)
  • Polyarthritis only
  • Chorea
  • Erythema marginatum
  • Subcutaneous nodules

Moderate-to-High-Risk Populations (e.g., developing countries, indigenous populations):

  • Carditis (clinical and/or subclinical)
  • Monoarthritis OR polyarthritis 1
  • Polyarthralgia (after excluding other causes) 1
  • Chorea
  • Erythema marginatum
  • Subcutaneous nodules

Key distinction: Monoarthritis and polyarthralgia are accepted as major manifestations only in moderate-to-high-risk populations. 1

Minor Manifestations

Clinical:

  • Fever (>38.5°C in low-risk; >37.5°C in moderate-to-high-risk populations) 1
  • Polyarthralgia (low-risk populations only; cannot use if polyarthralgia counted as major) 1
  • Monoarthralgia (moderate-to-high-risk populations only) 1

Laboratory:

  • Elevated acute phase reactants:
    • ESR ≥60 mm/hr (low-risk) or ≥30 mm/hr (moderate-to-high-risk) 1
    • CRP ≥3.0 mg/dL (low-risk) or ≥3.0 mg/dL (moderate-to-high-risk) 1
    • Use peak ESR values as they evolve during disease course 1
  • Prolonged PR interval on ECG (age-adjusted) 1, 5

Critical rule: Joint manifestations can only be counted in either the major OR minor category, never both in the same patient. 1

Diagnostic Algorithm

  1. Confirm recent GAS infection (throat culture/RADT or elevated ASO/anti-DNase B) 1

  2. Assess population risk (determines which manifestations qualify as major) 1

  3. Apply Jones Criteria:

    • 2 major manifestations, OR
    • 1 major + 2 minor manifestations 1, 5
  4. Exclude alternative diagnoses: Lyme disease, serum sickness, drug reactions, post-streptococcal reactive arthritis, infective endocarditis, congenital valve abnormalities 1, 6

Role of Echocardiography

Subclinical carditis detected by Doppler echocardiography is now accepted as a major manifestation, representing a major change from 1992 criteria. 1, 7 This is critical because:

  • Clinical detection of soft murmurs is difficult with tachycardia 8
  • Doppler/color flow mapping detects minor degrees of valvular regurgitation missed on auscultation 8
  • Pathological mitral regurgitation in rheumatic fever shows specific features: jet length >2 cm, peak velocity >3.0 m/s, holosystolic jet 1

However, echocardiography findings must be interpreted carefully to distinguish rheumatic valvulitis from congenital abnormalities (bicuspid aortic valve, cleft mitral valve, mitral valve prolapse) and infective endocarditis. 1

Special Scenarios

Recurrent Rheumatic Fever:

In patients with documented prior rheumatic fever or rheumatic heart disease and confirmed GAS infection, 2 major OR 1 major + 2 minor OR 3 minor manifestations may suffice for diagnosis. 1 When only minor manifestations are present, exclude other causes before diagnosing recurrence. 1

"Possible" Rheumatic Fever:

When clinical presentation doesn't fulfill Jones Criteria but suspicion remains high (particularly in high-incidence settings), consider 12 months of secondary prophylaxis followed by reevaluation including repeat echocardiogram. 1

Exceptions to Jones Criteria:

  • Chorea alone may be sufficient (often presents late when other manifestations have resolved) 5
  • Indolent carditis discovered months after infection 5

Common Pitfalls to Avoid

  • Do not use ASO/anti-DNase B to diagnose acute pharyngitis - these reflect past infection only and remain elevated for months 2, 3
  • Do not diagnose rheumatic fever in children <3 years old unless exceptional circumstances exist, as it's extremely rare in this age group 1
  • Do not count joint manifestations in both major and minor categories for the same patient 1
  • Do not rely on echocardiography alone without clinical context - physiological regurgitation is common 1
  • Remember age-specific normal values for ASO titers are higher in school-age children than adults 2, 4
  • Distinguish chronic GAS carriers with viral pharyngitis from acute infection - carriers lack rising antibody titers 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.